You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Myeloablative Conditioning Regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

Recruiting
  • Kidney Transplantation
  • TCD601
  • San Francisco, California
  • +4 more
Oct 28, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

Completed
Has Results
  • Single Umbilical Cord Blood Transplantation
  • +6 more
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

    Recruiting
    • Myeloid Malignancies
    • fractionated busulfan-based conditioning regimen
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 29, 2023

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

    Recruiting
    • Leukemia, Myeloid, Acute
    • +5 more
    • Melbourne, Victoria, Australia
      Melbourne Health
    Jun 19, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

    Terminated
    • Acute Myeloid Leukemia
    • +3 more
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Feb 22, 2022

    Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +3 more
    • anti-thymocyte globulin
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Oct 30, 2020

    Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

    Recruiting
    • Non Malignant Diseases
    • +2 more
    • RIC: Distal Campath
    • +2 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Mar 8, 2022

    Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

    Recruiting
    • Cytarabine+Thiotepa + Fludarabine + Busulfan
    • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • cytarabine+thiotepa+ fludarabine + busulfan
    • Hangzhou, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 26, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in United States (NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • NGS-MRD
    • Myeloablative allogeneic HCT with a non-TBI conditioning regimen
    • Birmingham, Alabama
    • +23 more
    Aug 20, 2021

    Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

    Active, not recruiting
    • Sickle Cell Disease
    • Hemoglobinopathies
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Dec 20, 2021

    Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

    Completed
    Has Results
    • Leukemia
    • +4 more
    • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 10, 2022

    Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

    Active, not recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

    Recruiting
    • Severe Sickle Cell Disease
    • +5 more
    • RIC regimen
    • GVHD prophylaxis regimen
    • New Haven, Connecticut
    • +1 more
    Feb 4, 2022

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

    Not yet recruiting
    • Sickle Cell Disease
    • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 4, 2023

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

    Completed
    • Severe Aplastic Anemia
    • Bone Marrow Failure Syndromes
    • Bone marrow transplant
    • +7 more
    • Baltimore, Maryland
    • +1 more
    Feb 10, 2022